PF-44901 |
CORPOTASIN LP 1500 mg Tabletas de liberación prolongada |
2026-12-14 |
|
Armstrong Laboratorios De Mexico S.A. De C.V. |
Mexico
|
Centro Distribuidor, Sociedad Anónima |
Bagó De Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-44065 |
VIVITAR 25 mg Tabletas |
2025-01-11 |
|
Armstrong Laboratorios De Mexico S.A. De C.V. |
Mexico
|
Resco |
Bagó De Guatemala |
ERETZ |
Centro Distribuidor, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-44080 |
VIVITAR 100 mg Tableta |
2025-01-14 |
|
Armstrong Laboratorios De Mexico S.A. De C.V. |
Mexico
|
Resco |
Centro Distribuidor, Sociedad Anónima |
Bagó De Guatemala |
ERETZ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-45101 |
ANGIOTROFIN 2 % Gel tópico |
2025-09-09 |
|
Armstrong Laboratorios De Mexico S.A. De C.V. |
Mexico
|
Bagó De Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-45829 |
ADIMOD 800 mg/7 mL Solución oral |
2026-11-16 |
|
Armstrong Laboratorios De Mexico S.A. De C.V. |
Mexico
|
Centro Distribuidor, Sociedad Anónima |
Bagó De Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-45804 |
ADIMOD 400 mg/7 mL Solución oral |
2026-06-29 |
|
Armstrong Laboratorios De Mexico S.A. De C.V. |
Mexico
|
Centro Distribuidor, Sociedad Anónima |
Bagó De Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-48576 |
NOVO HERKLIN 2000 5% Crema tópica |
2028-03-03 |
|
Armstrong Laboratorios De Mexico S.A. De C.V. |
Mexico
|
Centro Distribuidor, Sociedad Anónima |
Bagó De Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-12159 |
HERKLIN 1 % locion |
2008-01-05 |
|
Armstrong Laboratorios De Mexico S.A. De C.V. |
Mexico
|
Bago De Guatemala |
Centro Distribuidor S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-12107 |
ATEMPERATOR 200 mg Tabletas recubiertas entéricas |
2027-04-28 |
|
Armstrong Laboratorios De Mexico S.A. De C.V. |
Mexico
|
Bagó De Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-12104 |
ATEMPERATOR 500 mg Tabletas recubiertas entéricas |
2026-12-02 |
|
Armstrong Laboratorios De Mexico S.A. De C.V. |
Mexico
|
Centro Distribuidor, Sociedad Anónima |
Bagó De Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|